Henry I. Miller

Robert Wesson Fellow in Scientific Philosophy and Public Policy
Biography: 

Henry I. Miller, MS, MD, is the Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution. His research focuses on public policy toward science and technology, encompassing a number of areas, including pharmaceutical development, genetic engineering in agriculture, models for regulatory reform, and the emergence of new viral diseases.

Miller served for fifteen years at the US Food and Drug Administration (FDA) in a number of posts. He was the medical reviewer for the first genetically engineered drugs to be evaluated by the FDA and thus instrumental in the rapid licensing of human insulin and human growth hormone. Thereafter, he was a special assistant to the FDA commissioner and the founding director of the FDA's Office of Biotechnology. During his government service, Miller participated frequently on various expert and policy panels as a representative of the FDA or the US government. As a government official, Miller received numerous awards and citations.

Since coming to the Hoover Institution, Miller has become well known not only for his contributions to scholarly journals but also for his articles and books that make science, medicine, and technology accessible. His work has been widely published in many languages. Monographs include Policy Controversy in Biotechnology: An Insider's View; To America's Health: A Model for Reform of the Food and Drug Administration; and The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution. Barron's selected The Frankenfood Myth as one of the 25 Best Books of 2004. In addition, Miller has published extensively in a wide spectrum of scholarly journals and popular publications worldwide, including The Lancet, Journal of the American Medical Association, Science, the Nature family of journals, Chronicle of Higher Education, Forbes, National Review, Wall Street Journal, New York Times, the Guardian, Defining Ideas, and the Financial Times. He is a regulator contributor to Forbes.com and frequently appears on the nationally syndicated radio programs of John Batchelor and Lars Larson.

Miller was selected by the editors of Nature Biotechnology as one of the people who had made the "most significant contributions" to biotechnology during the previous decade. He serves on numerous editorial boards.

Filter By:

Topic

Type

Recent Commentary

Analysis and Commentary

'GMO' Labeling: Good Intentions And Ignorance Can Yield Bad Outcomes

by Henry I. Millervia Forbes
Wednesday, May 25, 2016

Perhaps as part of its ongoing efforts to misinform its readers about genetic engineering, the New York Times on May 16 published yet another misguided and misleading article. The op-ed by Jason Kelly, the “co-founder and chief executive” of a wannabe-biotech company, no less, actually goes beyond misguided and misleading; it is extraordinarily stupid and counterproductive.

Analysis and Commentary

National Academy Of Sciences' 'GMO' Report Does Science No Favors

by Henry I. Millervia Forbes
Tuesday, May 24, 2016

The National Academy of Sciences provides “science-based advice on critical issues affecting the nation,” according to its website. Because its reports are often relied on by Congress and government agencies for formulating legislation and policy, it’s essential that they are of high quality.

Analysis and Commentary

Errors, Bias And Conflicts Of Interest Make UN Agency Contender For Worst Regulator Ever

by Henry I. Millervia Forbes
Wednesday, May 18, 2016

Bias, conflicts of interest and scientific illiteracy have made things tough for science-based public policy in recent decades. Anti-vaccine activism and the boosters of organic agriculture come to mind.

Mark Bittman Eats His Words--And Chokes

by Julie Kelly, Henry I. Miller
Monday, May 16, 2016

What happens when a sanctimonious, know-nothing foodie who has made a career out of peddling false and misleading information about food production technologies and big agribusiness decides to cash in by exploiting his favorite food fads?

Analysis and Commentary

A Risk-Based Approach To The Regulation Of Genetically Engineered Organisms

by Gregory Conko, Drew L. Kershen, Henry I. Miller, Wayne A Parrottvia Nature
Friday, May 6, 2016

Current regulatory regimes for genetically engineered crops fail to use a scientifically defensible approach or tailor the degree of regulatory review to the level of actual hazard or risk. 

Analysis and Commentary

Deadly Dysfunction: Bureaucratic Snafus Delay A Novel Approach To Zika

by Henry I. Miller, John Cohrssenvia Forbes
Wednesday, May 4, 2016

Abandoning earlier caution about the relationship between the Zika virus and various serious possible sequelae, including microcephaly (a devastating condition in which babies are born with abnormally small heads and brains), CDC scientists have confirmed cause and effect.

Blank Section (Placeholder)Analysis and Commentary

The EPA Bows To Activists

by Henry I. Millervia Defining Ideas
Thursday, April 21, 2016

In Washington, politics and lobbying trump science at the expense of the economy. 

Analysis and Commentary

The GMO Circus Comes To Congress And It's Not Fun

by Julie Kelly, Henry I. Millervia Forbes
Wednesday, April 20, 2016

Like Nero fiddling while Rome burned, some politicians have a hard time setting priorities.

Blank Section (Placeholder)

Fishmongers

by Henry I. Millervia Hoover Digest
Monday, April 18, 2016

Genetically modified salmon have finally been approved. Why did they have to spend so much time swimming upstream?

Analysis and Commentary

The USDA's Meaningless Organic Label

by John Cohrssen, Henry I. Millervia Cato Institute
Monday, April 18, 2016

The courts could end this deceptive marketing program.

Pages